Free Trial

Arteris, Inc. (NASDAQ:AIP) CEO K Charles Janac Sells 2,057 Shares

Arteris logo with Computer and Technology background

Arteris, Inc. (NASDAQ:AIP - Get Free Report) CEO K Charles Janac sold 2,057 shares of Arteris stock in a transaction dated Wednesday, June 4th. The shares were sold at an average price of $7.83, for a total value of $16,106.31. Following the completion of the sale, the chief executive officer now owns 305,664 shares of the company's stock, valued at $2,393,349.12. The trade was a 0.67% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

K Charles Janac also recently made the following trade(s):

  • On Monday, June 2nd, K Charles Janac sold 1,246 shares of Arteris stock. The stock was sold at an average price of $7.70, for a total transaction of $9,594.20.
  • On Wednesday, April 2nd, K Charles Janac sold 7,150 shares of Arteris stock. The stock was sold at an average price of $7.12, for a total transaction of $50,908.00.

Arteris Trading Up 1.0%

Shares of NASDAQ AIP traded up $0.08 during trading on Monday, hitting $8.01. 285,413 shares of the company were exchanged, compared to its average volume of 205,142. Arteris, Inc. has a 12-month low of $5.46 and a 12-month high of $12.64. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.17 and a current ratio of 1.17. The company has a fifty day moving average price of $6.89 and a 200-day moving average price of $8.60. The firm has a market capitalization of $336.24 million, a PE ratio of -9.21 and a beta of 1.37.

Institutional Investors Weigh In On Arteris

A number of institutional investors have recently made changes to their positions in AIP. Needham Investment Management LLC lifted its holdings in shares of Arteris by 2.5% in the first quarter. Needham Investment Management LLC now owns 2,812,500 shares of the company's stock valued at $19,434,000 after buying an additional 67,500 shares during the period. Samjo Management LLC raised its position in Arteris by 0.9% during the fourth quarter. Samjo Management LLC now owns 1,157,250 shares of the company's stock valued at $11,792,000 after buying an additional 10,000 shares during the period. Acadian Asset Management LLC raised its position in Arteris by 40.6% during the first quarter. Acadian Asset Management LLC now owns 900,723 shares of the company's stock valued at $6,222,000 after buying an additional 260,277 shares during the period. Next Century Growth Investors LLC increased its position in Arteris by 46.4% in the 1st quarter. Next Century Growth Investors LLC now owns 407,721 shares of the company's stock worth $2,817,000 after purchasing an additional 129,143 shares during the last quarter. Finally, Federated Hermes Inc. increased its position in Arteris by 97.2% in the 1st quarter. Federated Hermes Inc. now owns 327,119 shares of the company's stock worth $2,260,000 after purchasing an additional 161,241 shares during the last quarter. 64.36% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on AIP shares. Rosenblatt Securities reiterated a "buy" rating and issued a $14.00 price target on shares of Arteris in a report on Wednesday, May 21st. Northland Securities increased their price target on shares of Arteris from $14.00 to $16.00 and gave the stock an "outperform" rating in a report on Wednesday, February 19th.

Get Our Latest Stock Report on AIP

About Arteris

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Further Reading

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Should You Invest $1,000 in Arteris Right Now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines